Key Financial Data Of Group

Delta-Fly Pharma, Inc. - Filing #7717381

Concept As at
2018-09-30
2018-07-01 to
2018-09-30
2018-04-01 to
2018-09-30
As at
2018-03-31
2017-04-01 to
2018-03-31
Key financial data of group
Business results of group
Ordinary profit (loss)
-277,665,000 JPY
-244,505,000 JPY
Net assets
543,874,000 JPY
822,493,000 JPY
Total assets
588,554,000 JPY
864,145,000 JPY
Basic earnings (loss) per share
-48.04
-77.29
-71.20
Diluted earnings per share
Equity-to-asset ratio
0.924 xbrli:pure
0.952 xbrli:pure
Net cash provided by (used in) operating activities
-247,429,000 JPY
100,042,000 JPY
Net cash provided by (used in) investing activities
JPY
JPY
Net cash provided by (used in) financing activities
-5,396,000 JPY
292,724,000 JPY
Cash and cash equivalents
528,414,000 JPY
781,250,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.